World Health Organization Sounds Alert Over Severe Shortage of Obesity Injections
Less than a tenth of individuals that would benefit from weight-loss injections including Wegovy can access them, caution the World Health Organization as it publishes its inaugural recommendations on the medications.
With more than one billion individuals worldwide currently obese, it is urging more widespread and fairer access to this class of drugs.
Based on estimates, in excess of 2,000,000,000 could be living with obesity by 2030 unless action is taken.
"Our latest guidelines recognises that excess weight is a lifelong illness that can be treated with holistic and ongoing care," remarked its chief Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and supply-chain constraints are key hurdles to widespread availability to the jabs that can aid individuals in losing considerable weight, explains the body.
Skinny Jab Scarcity
Despite the current best projected outlook, the manufacturing of such drugs could only cover about 100 million people – less than 10% of those who need them, according to the health organization.
The guideline urges countries and companies to expand access, through strategies like licensing agreements.
Exclusive production rights on the active ingredient – the core component of Novo Nordisk's Wegovy – is due to expire in several countries in 2026.
The Way Weight-Loss Drugs Work
These medications replicate a biological compound to reduce digestion speed, reduce hunger and boost the sense of being full so users reduce food intake.
Patients usually see weight reduction in the initial weeks of beginning the regular doses.
Studies indicates people may see weight return after a year of halting the drug, because their normal hunger resume.
To be carrying excess weight raises your risk for contracting medical conditions, such as type 2 diabetes, heart disease, stroke, and some cancers.
Obesity impacts individuals in every country and was responsible for 3.7 million fatalities worldwide in 2024, per the health agency.
